Early Predictors of Substantial Weight Gain in Bipolar Patients Treated with Olanzapine
Authors:
- Ilya LipkovichILIlya Lipkovich
- Leslie CitromeLCLeslie Citrome
- Roy PerlisRPRoy Perlis
- Walter DeberdtWDWalter Deberdt
- John P. HoustonJHJohn P. Houston
- Jonna AhlJAJonna Ahl
- Thomas HardyTHThomas Hardy
- 1 June 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Clinical Psychopharmacology
- Vol. 26 (3) , 316-320
Abstract
To determine predictors of substantial weight gain (SWG) during treatment of bipolar disorder with olanzapine, data were pooled from 4 long-term randomized, multicenter studies in patients with bipolar mania or mixed mania (N = 948 at initiation of olanzapine). SWG was defined as gaining 5 kg or 7% of initial weight in 30 ± 2 weeks. Logistic regression estimated odds ratios associated with early weight gain and baseline risk factors for predicting SWG. A classification system to identify patients at risk for SWG was constructed by recursive data partitioning. Baseline characteristics significantly associated with SWG included younger age, nonwhite ethnicity, lower body mass index (BMI), nonrapid cycling, and psychotic features. Weight gain of 2 or more kg in the first 3 weeks of therapy predicted SWG by 30 weeks (sensitivity = 57%; specificity = 71%). A classification system with thresholds for early weight gain, baseline BMI, and ethnicity further improved SWG predictability (sensitivity = 79%; specificity = 70%). In conclusion, patients with bipolar disorder who gained 2 to 3 kg during the first 3 weeks of treatment with olanzapine, SWG was predicted after 30 weeks of treatment. Patients with less pronounced early weight gain might still be at risk for later SWG if they have close to normal BMI (≤27 kg/m2) at treatment initiation.Keywords
This publication has 18 references indexed in Scilit:
- Bipolar Disorder, Obesity, and Pharmacotherapy-Associated Weight GainThe Journal of Clinical Psychiatry, 2003
- A 12-Week, Double-blind Comparison of Olanzapine vs Haloperidol in the Treatment of Acute ManiaArchives of General Psychiatry, 2003
- Schizophrenia and weight management: a systematic review of interventions to control weightActa Psychiatrica Scandinavica, 2003
- Correlates of Overweight and Obesity in 644 Patients With Bipolar DisorderThe Journal of Clinical Psychiatry, 2002
- Long-Term Olanzapine Therapy in the Treatment of Bipolar I DisorderThe Journal of Clinical Psychiatry, 2001
- A Randomized, Placebo-Controlled 12-Month Trial of Divalproex and Lithium in Treatment of Outpatients With Bipolar I DisorderArchives of General Psychiatry, 2000
- Novel AntipsychoticsThe Journal of Clinical Psychiatry, 1999
- The Distribution of Body Mass Index Among Individuals With and Without SchizophreniaThe Journal of Clinical Psychiatry, 1999
- Peptides and Psychiatry, Part 1: How Synthesis of Neuropeptides Differs From Classical Neurotransmitter SynthesisThe Journal of Clinical Psychiatry, 1999
- The unhealthy lifestyle of people with schizophreniaPsychological Medicine, 1999